BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Michor F, Iwasa Y, Nowak MA. Dynamics of cancer progression. Nat Rev Cancer 2004;4:197-205. [PMID: 14993901 DOI: 10.1038/nrc1295] [Cited by in Crossref: 268] [Cited by in F6Publishing: 218] [Article Influence: 14.9] [Reference Citation Analysis]
Number Citing Articles
1 Al-hashimi F, J. Diaz-cano S; 1 Salmaniya Medical Complex, Department of Pathology, Manama, Bahrain, 2 King’s college hospital, Department of Histopathology, London, SE5 9RS, United Kingdom. . AIMS Molecular Science 2018;5:14-62. [DOI: 10.3934/molsci.2018.1.14] [Reference Citation Analysis]
2 Dobata S, Tsuji K. A cheater lineage in a social insect: Implications for the evolution of cooperation in the wild. Commun Integr Biol 2009;2:67-70. [PMID: 19704890 DOI: 10.4161/cib.7466] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
3 Fontanari JF, Serva M. Effect of Migration in a Diffusion Model for Template Coexistence in Protocells. Bull Math Biol 2014;76:654-72. [DOI: 10.1007/s11538-014-9937-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
4 Kimmel M, Corey S. Stochastic Hypothesis of Transition from Inborn Neutropenia to AML: Interactions of Cell Population Dynamics and Population Genetics. Front Oncol 2013;3:89. [PMID: 23641360 DOI: 10.3389/fonc.2013.00089] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
5 Dingli D. Computational and systems biology of cancer. Comp Sys Onco 2021;1. [DOI: 10.1002/cso2.1005] [Reference Citation Analysis]
6 Lähnemann D, Köster J, Szczurek E, McCarthy DJ, Hicks SC, Robinson MD, Vallejos CA, Campbell KR, Beerenwinkel N, Mahfouz A, Pinello L, Skums P, Stamatakis A, Attolini CS, Aparicio S, Baaijens J, Balvert M, Barbanson B, Cappuccio A, Corleone G, Dutilh BE, Florescu M, Guryev V, Holmer R, Jahn K, Lobo TJ, Keizer EM, Khatri I, Kielbasa SM, Korbel JO, Kozlov AM, Kuo TH, Lelieveldt BPF, Mandoiu II, Marioni JC, Marschall T, Mölder F, Niknejad A, Raczkowski L, Reinders M, Ridder J, Saliba AE, Somarakis A, Stegle O, Theis FJ, Yang H, Zelikovsky A, McHardy AC, Raphael BJ, Shah SP, Schönhuth A. Eleven grand challenges in single-cell data science. Genome Biol 2020;21:31. [PMID: 32033589 DOI: 10.1186/s13059-020-1926-6] [Cited by in Crossref: 197] [Cited by in F6Publishing: 139] [Article Influence: 98.5] [Reference Citation Analysis]
7 Bapat SA. Evolution of cancer stem cells. Semin Cancer Biol 2007;17:204-13. [PMID: 16787749 DOI: 10.1016/j.semcancer.2006.05.001] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 2.6] [Reference Citation Analysis]
8 Michor F, Iwasa Y, Vogelstein B, Lengauer C, Nowak MA. Can chromosomal instability initiate tumorigenesis? Semin Cancer Biol 2005;15:43-9. [PMID: 15613287 DOI: 10.1016/j.semcancer.2004.09.007] [Cited by in Crossref: 125] [Cited by in F6Publishing: 109] [Article Influence: 7.4] [Reference Citation Analysis]
9 Malaguti G, Singh PP, Isambert H. On the retention of gene duplicates prone to dominant deleterious mutations. Theor Popul Biol 2014;93:38-51. [PMID: 24530892 DOI: 10.1016/j.tpb.2014.01.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
10 Lyons JG, Lobo E, Martorana AM, Myerscough MR. Clonal diversity in carcinomas: its implications for tumour progression and the contribution made to it by epithelial-mesenchymal transitions. Clin Exp Metastasis 2008;25:665-77. [PMID: 18071912 DOI: 10.1007/s10585-007-9134-2] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 3.4] [Reference Citation Analysis]
11 Baker SG, Kramer BS. Paradoxes in carcinogenesis: new opportunities for research directions. BMC Cancer 2007;7:151. [PMID: 17683619 DOI: 10.1186/1471-2407-7-151] [Cited by in Crossref: 54] [Cited by in F6Publishing: 41] [Article Influence: 3.6] [Reference Citation Analysis]
12 Fagundes CP, Murdock KW, Chirinos DA, Green PA. Biobehavioral Pathways to Cancer Incidence, Progression, and Quality of Life. Curr Dir Psychol Sci 2017;26:548-53. [DOI: 10.1177/0963721417720958] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
13 Ji L, Minna JD, Roth JA. 3p21.3 tumor suppressor cluster: prospects for translational applications. Future Oncology 2005;1:79-92. [DOI: 10.1517/14796694.1.1.79] [Cited by in Crossref: 67] [Cited by in F6Publishing: 62] [Article Influence: 3.9] [Reference Citation Analysis]
14 Enderling H, Chaplain MA, Anderson AR, Vaidya JS. A mathematical model of breast cancer development, local treatment and recurrence. Journal of Theoretical Biology 2007;246:245-59. [DOI: 10.1016/j.jtbi.2006.12.010] [Cited by in Crossref: 120] [Cited by in F6Publishing: 87] [Article Influence: 8.0] [Reference Citation Analysis]
15 Michor F, Nowak MA, Iwasa Y. Stochastic dynamics of metastasis formation. J Theor Biol. 2006;240:521-530. [PMID: 16343545 DOI: 10.1016/j.jtbi.2005.10.021] [Cited by in Crossref: 48] [Cited by in F6Publishing: 39] [Article Influence: 2.8] [Reference Citation Analysis]
16 Greaves M. Evolutionary determinants of cancer. Cancer Discov. 2015;5:806-820. [PMID: 26193902 DOI: 10.1158/2159-8290.cd-15-0439] [Cited by in Crossref: 215] [Cited by in F6Publishing: 118] [Article Influence: 30.7] [Reference Citation Analysis]
17 Wu D, Li H, Du W, Ji X, Liu W, Huang S, Xiao Y. Mathematical modeling of therapeutic strategies for myeloid malignancies. Pathol Oncol Res 2012;18:939-47. [PMID: 22843097 DOI: 10.1007/s12253-012-9524-x] [Reference Citation Analysis]
18 Bianca C, Dogbe C. Kinetic models coupled with Gaussian thermostats: macroscopic frameworks. Nonlinearity 2014;27:2771-803. [DOI: 10.1088/0951-7715/27/12/2771] [Cited by in Crossref: 23] [Cited by in F6Publishing: 7] [Article Influence: 2.9] [Reference Citation Analysis]
19 Bellomo N, Knopoff D, Soler J. ON THE DIFFICULT INTERPLAY BETWEEN LIFE, "COMPLEXITY", AND MATHEMATICAL SCIENCES. Math Models Methods Appl Sci 2013;23:1861-913. [DOI: 10.1142/s021820251350053x] [Cited by in Crossref: 105] [Article Influence: 11.7] [Reference Citation Analysis]
20 Patel LR, Nykter M, Chen K, Zhang W. Cancer genome sequencing: understanding malignancy as a disease of the genome, its conformation, and its evolution. Cancer Lett. 2013;340:152-160. [PMID: 23111104 DOI: 10.1016/j.canlet.2012.10.018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
21 Bellomo N, Li NK, Maini PK. ON THE FOUNDATIONS OF CANCER MODELLING: SELECTED TOPICS, SPECULATIONS, AND PERSPECTIVES. Math Models Methods Appl Sci 2011;18:593-646. [DOI: 10.1142/s0218202508002796] [Cited by in Crossref: 290] [Article Influence: 26.4] [Reference Citation Analysis]
22 Kaveh K, Kohandel M, Sivaloganathan S. Replicator dynamics of cancer stem cell: Selection in the presence of differentiation and plasticity. Math Biosci 2016;272:64-75. [PMID: 26683105 DOI: 10.1016/j.mbs.2015.11.012] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 2.1] [Reference Citation Analysis]
23 Bunimovich-mendrazitsky S, Shklyar B. Optimization of Combined Leukemia Therapy by Finite-Dimensional Optimal Control Modeling. J Optim Theory Appl 2017;175:218-35. [DOI: 10.1007/s10957-017-1161-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
24 Chu XY, Jiang LH, Zhou XH, Cui ZJ, Zhang HY. Evolutionary Origins of Cancer Driver Genes and Implications for Cancer Prognosis. Genes (Basel) 2017;8:E182. [PMID: 28708071 DOI: 10.3390/genes8070182] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
25 Dy GK, Adjei AA. Obtacles and opportunities in the clinical development of targeted therapeutics. In: Herrling PL, Matter A, Schultz RM, editors. Advances in Targeted Cancer Therapy. Basel: Birkhäuser-Verlag; 2005. pp. 19-41. [DOI: 10.1007/3-7643-7414-4_2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
26 Gerstung M, Beerenwinkel N. Waiting Time Models of Cancer Progression. Mathematical Population Studies 2010;17:115-35. [DOI: 10.1080/08898480.2010.490994] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
27 Irurzun-Arana I, Rackauckas C, McDonald TO, Trocóniz IF. Beyond Deterministic Models in Drug Discovery and Development. Trends Pharmacol Sci 2020;41:882-95. [PMID: 33032836 DOI: 10.1016/j.tips.2020.09.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Rajakumar T, Pugalendhi P, Thilagavathi S. Protective Effect of Allyl Isothiocyanate on Glycoprotein Components in 7,12-dimethylbenz(a)anthracene Induced Mammary Carcinoma in Rats. Indian J Clin Biochem 2018;33:171-7. [PMID: 29651207 DOI: 10.1007/s12291-017-0663-4] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
29 Deutsch A, Friedl P, Preziosi L, Theraulaz G. Multi-scale analysis and modelling of collective migration in biological systems. Philos Trans R Soc Lond B Biol Sci 2020;375:20190377. [PMID: 32713301 DOI: 10.1098/rstb.2019.0377] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
30 Arivazhagan L, Sorimuthu Pillai S. Tangeretin, a citrus pentamethoxyflavone, exerts cytostatic effect via p53/p21 up-regulation and suppresses metastasis in 7,12-dimethylbenz(α)anthracene-induced rat mammary carcinoma. J Nutr Biochem 2014;25:1140-53. [PMID: 25151216 DOI: 10.1016/j.jnutbio.2014.06.007] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 5.3] [Reference Citation Analysis]
31 Lin L, Lin DC. Biological Significance of Tumor Heterogeneity in Esophageal Squamous Cell Carcinoma. Cancers (Basel) 2019;11:E1156. [PMID: 31409002 DOI: 10.3390/cancers11081156] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
32 Michor F, Iwasa Y, Nowak MA. The age incidence of chronic myeloid leukemia can be explained by a one-mutation model. Proc Natl Acad Sci U S A 2006;103:14931-4. [PMID: 17001000 DOI: 10.1073/pnas.0607006103] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 3.6] [Reference Citation Analysis]
33 Sewalt L, Harley K, van Heijster P, Balasuriya S. Influences of Allee effects in the spreading of malignant tumours. Journal of Theoretical Biology 2016;394:77-92. [DOI: 10.1016/j.jtbi.2015.12.024] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
34 Rădulescu I, Cândea D, Halanay A. Optimal control analysis of a leukemia model under imatinib treatment. Mathematics and Computers in Simulation 2016;121:1-11. [DOI: 10.1016/j.matcom.2015.03.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
35 Warth A, Endris V, Stenzinger A, Penzel R, Harms A, Duell T, Abdollahi A, Lindner M, Schirmacher P, Muley T, Dienemann H, Fink L, Morresi-Hauf A, Pfarr N, Weichert W. Genetic changes of non-small cell lung cancer under neoadjuvant therapy. Oncotarget 2016;7:29761-9. [PMID: 27105513 DOI: 10.18632/oncotarget.8858] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
36 George JT, Levine H. Stochastic modeling of tumor progression and immune evasion. J Theor Biol 2018;458:148-55. [PMID: 30218648 DOI: 10.1016/j.jtbi.2018.09.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
37 Basanta D, Anderson ARA. Homeostasis Back and Forth: An Ecoevolutionary Perspective of Cancer. Cold Spring Harb Perspect Med 2017;7:a028332. [PMID: 28289244 DOI: 10.1101/cshperspect.a028332] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 5.4] [Reference Citation Analysis]
38 Zhan X, Cheng J, Huang Z, Han Z, Helm B, Liu X, Zhang J, Wang TF, Ni D, Huang K. Correlation Analysis of Histopathology and Proteogenomics Data for Breast Cancer. Mol Cell Proteomics 2019;18:S37-51. [PMID: 31285282 DOI: 10.1074/mcp.RA118.001232] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
39 Hassani H, Machado JAT, Avazzadeh Z, Safari E, Mehrabi S. Optimal solution of the fractional order breast cancer competition model. Sci Rep 2021;11:15622. [PMID: 34341390 DOI: 10.1038/s41598-021-94875-1] [Reference Citation Analysis]
40 Karev GP, Novozhilov AS, Koonin EV. Mathematical modeling of tumor therapy with oncolytic viruses: effects of parametric heterogeneity on cell dynamics. Biol Direct 2006;1:30. [PMID: 17018145 DOI: 10.1186/1745-6150-1-30] [Cited by in Crossref: 34] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
41 Liu Y, Song J, Li Y, Zhao Y, Ju Q, Zhou G, Li G. Monoclonal antibody preparation and expression profile analysis of a novel hepatoma associated gene. Pathol Oncol Res 2014;20:349-56. [PMID: 24214030 DOI: 10.1007/s12253-013-9703-4] [Reference Citation Analysis]
42 Srivastava S, Grizzle WE. Biomarkers and the genetics of early neoplastic lesions. Cancer Biomark 2010;9:41-64. [PMID: 22112469 DOI: 10.3233/CBM-2011-0204] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
43 West J, Hasnain Z, Mason J, Newton PK. The prisoner's dilemma as a cancer model. Converg Sci Phys Oncol 2016;2:035002. [PMID: 29177084 DOI: 10.1088/2057-1739/2/3/035002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
44 Fu F, Nowak MA, Bonhoeffer S. Spatial heterogeneity in drug concentrations can facilitate the emergence of resistance to cancer therapy. PLoS Comput Biol 2015;11:e1004142. [PMID: 25789469 DOI: 10.1371/journal.pcbi.1004142] [Cited by in Crossref: 72] [Cited by in F6Publishing: 58] [Article Influence: 10.3] [Reference Citation Analysis]
45 Grossmann P, Cristea S, Beerenwinkel N. Clonal evolution driven by superdriver mutations. BMC Evol Biol 2020;20:89. [PMID: 32689942 DOI: 10.1186/s12862-020-01647-y] [Reference Citation Analysis]
46 Tan H, Bao J, Zhou X. Genome-wide mutational spectra analysis reveals significant cancer-specific heterogeneity. Sci Rep 2015;5:12566. [PMID: 26212640 DOI: 10.1038/srep12566] [Cited by in Crossref: 62] [Cited by in F6Publishing: 51] [Article Influence: 8.9] [Reference Citation Analysis]
47 Pizzolato N, Persano Adorno D, Valenti D, Spagnolo B. Intermittent targeted therapies and stochastic evolution in patients affected by chronic myeloid leukemia. J Stat Mech 2016;2016:054032. [DOI: 10.1088/1742-5468/2016/05/054032] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
48 Måløy M, Måløy F, Lahoz-Beltrá R, Carlos Nuño J, Bru A. An extended Moran process that captures the struggle for fitness. Math Biosci 2019;308:81-104. [PMID: 30590062 DOI: 10.1016/j.mbs.2018.12.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
49 Lean C, Plutynski A. The evolution of failure: explaining cancer as an evolutionary process. Biol Philos 2016;31:39-57. [DOI: 10.1007/s10539-015-9511-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
50 Lavi O, Gottesman MM, Levy D. The dynamics of drug resistance: a mathematical perspective. Drug Resist Updat 2012;15:90-7. [PMID: 22387162 DOI: 10.1016/j.drup.2012.01.003] [Cited by in Crossref: 69] [Cited by in F6Publishing: 49] [Article Influence: 6.9] [Reference Citation Analysis]
51 Rădulescu IR, Cândea D, Halanay A. A study on stability and medical implications for a complex delay model for CML with cell competition and treatment. J Theor Biol 2014;363:30-40. [PMID: 25128235 DOI: 10.1016/j.jtbi.2014.08.009] [Cited by in Crossref: 5] [Article Influence: 0.6] [Reference Citation Analysis]
52 Roose T, Chapman SJ, Maini PK. Mathematical Models of Avascular Tumor Growth. SIAM Rev 2007;49:179-208. [DOI: 10.1137/s0036144504446291] [Cited by in Crossref: 346] [Article Influence: 23.1] [Reference Citation Analysis]
53 Beerenwinkel N, Greenman CD, Lagergren J. Computational Cancer Biology: An Evolutionary Perspective. PLoS Comput Biol 2016;12:e1004717. [PMID: 26845763 DOI: 10.1371/journal.pcbi.1004717] [Cited by in Crossref: 42] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
54 Halanay A, Cândea D, Rădulescu IR, Pujo-menjouet L. Existence and Stability of Limit Cycles in a Two-delays Model of Hematopoiesis Including Asymmetric Division. Math Model Nat Phenom 2014;9:58-78. [DOI: 10.1051/mmnp/20149105] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Crespi BJ, Summers K. Positive selection in the evolution of cancer. Biol Rev Camb Philos Soc 2006;81:407-24. [PMID: 16762098 DOI: 10.1017/S1464793106007056] [Cited by in Crossref: 68] [Cited by in F6Publishing: 39] [Article Influence: 4.3] [Reference Citation Analysis]
56 Sollazzo M, Genchi C, Paglia S, Di Giacomo S, Pession A, de Biase D, Grifoni D. High MYC Levels Favour Multifocal Carcinogenesis. Front Genet 2018;9:612. [PMID: 30619451 DOI: 10.3389/fgene.2018.00612] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
57 Jamieson-Lane A, Hauert C. Fixation probabilities on superstars, revisited and revised. J Theor Biol 2015;382:44-56. [PMID: 26122591 DOI: 10.1016/j.jtbi.2015.06.029] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 2.9] [Reference Citation Analysis]
58 Grizzi F. Cancer heterogeneity and drug metabolism: what we know and what we need to know. Future Oncology 2016;12:1317-9. [DOI: 10.2217/fon-2015-0039] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
59 Raynaud F, Mina M, Ciriello G. Dynamic Emergence of Observed and Hidden Intra-tumor Heterogeneity. iScience 2019;21:157-67. [PMID: 31655256 DOI: 10.1016/j.isci.2019.10.018] [Reference Citation Analysis]
60 Allen B, Nowak MA. Evolutionary shift dynamics on a cycle. J Theor Biol 2012;311:28-39. [PMID: 22814475 DOI: 10.1016/j.jtbi.2012.07.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
61 Johnston MD, Edwards CM, Bodmer WF, Maini PK, Chapman SJ. Examples of mathematical modeling: tales from the crypt. Cell Cycle 2007;6:2106-12. [PMID: 17873520 DOI: 10.4161/cc.6.17.4649] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
62 Marusyk A, Polyak K. Tumor heterogeneity: causes and consequences. Biochim Biophys Acta. 2010;1805:105-117. [PMID: 19931353 DOI: 10.1016/j.bbcan.2009.11.002] [Cited by in Crossref: 377] [Cited by in F6Publishing: 639] [Article Influence: 29.0] [Reference Citation Analysis]
63 Ma X, Wang Z. Anticancer drug discovery in the future: an evolutionary perspective. Drug Discov Today 2009;14:1136-42. [PMID: 19800414 DOI: 10.1016/j.drudis.2009.09.006] [Cited by in Crossref: 49] [Cited by in F6Publishing: 38] [Article Influence: 3.8] [Reference Citation Analysis]
64 Merlo LM, Pepper JW, Reid BJ, Maley CC. Cancer as an evolutionary and ecological process. Nat Rev Cancer. 2006;6:924-935. [PMID: 17109012 DOI: 10.1038/nrc2013] [Cited by in Crossref: 1058] [Cited by in F6Publishing: 871] [Article Influence: 66.1] [Reference Citation Analysis]
65 Michor F. Chromosomal instability and human cancer. Philos Trans R Soc Lond B Biol Sci 2005;360:631-5. [PMID: 15897185 DOI: 10.1098/rstb.2004.1617] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
66 Hormoz S. Stem cell population asymmetry can reduce rate of replicative aging. J Theor Biol 2013;331:19-27. [PMID: 23623948 DOI: 10.1016/j.jtbi.2013.04.018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
67 Ohtsuki H, Innan H. Forward and backward evolutionary processes and allele frequency spectrum in a cancer cell population. Theor Popul Biol 2017;117:43-50. [PMID: 28866007 DOI: 10.1016/j.tpb.2017.08.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
68 Aguilar-hidalgo D, Lemos M, Córdoba A. Evolutionary Dynamics in Gene Networks and Inference Algorithms. Computation 2015;3:99-113. [DOI: 10.3390/computation3010099] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
69 Li Y, Wu R. Functional mapping of growth and development. Biological Reviews 2010;85:207-16. [DOI: 10.1111/j.1469-185x.2009.00096.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
70 Domazet-Loso T, Tautz D. Phylostratigraphic tracking of cancer genes suggests a link to the emergence of multicellularity in metazoa. BMC Biol 2010;8:66. [PMID: 20492640 DOI: 10.1186/1741-7007-8-66] [Cited by in Crossref: 160] [Cited by in F6Publishing: 141] [Article Influence: 13.3] [Reference Citation Analysis]
71 Deshpande N, Ramesh A, Nandi D, Nguyen A, Brouillard A, Kulkarni A. Supramolecular Polysaccharide Nanotheranostics that Inhibit Cancer Cells Growth and Monitor Targeted Therapy Response. Nanotheranostics 2020;4:156-72. [PMID: 32483521 DOI: 10.7150/ntno.44703] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
72 Roeder I, Glauche I. Pathogenesis, treatment effects, and resistance dynamics in chronic myeloid leukemia--insights from mathematical model analyses. J Mol Med (Berl) 2008;86:17-27. [PMID: 17661001 DOI: 10.1007/s00109-007-0241-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
73 Pizzolato N, Valenti D, Adorno D, Spagnolo B. Evolutionary dynamics of imatinib-treated leukemic cells by stochastic approach. Open Physics 2009;7. [DOI: 10.2478/s11534-009-0020-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
74 Isabella S, Mirunalini S. 3, 3′-Diindolylmethane-encapsulated chitosan nanoparticles accelerate molecular events during chemical carcinogen-induced mammary cancer in Sprague Dawley rats. Breast Cancer 2019;26:499-509. [DOI: 10.1007/s12282-019-00950-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
75 Vendramin R, Litchfield K, Swanton C. Cancer evolution: Darwin and beyond. EMBO J 2021;40:e108389. [PMID: 34459009 DOI: 10.15252/embj.2021108389] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
76 Haeno H, Levine RL, Gilliland DG, Michor F. A progenitor cell origin of myeloid malignancies. Proc Natl Acad Sci U S A 2009;106:16616-21. [PMID: 19805346 DOI: 10.1073/pnas.0908107106] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 3.2] [Reference Citation Analysis]
77 Weiss RA. Multistage carcinogenesis. Br J Cancer 2004;91:1981-2. [PMID: 15599379 DOI: 10.1038/sj.bjc.6602318] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
78 Novozhilov AS, Karev GP, Koonin EV. Biological applications of the theory of birth-and-death processes. Brief Bioinform 2006;7:70-85. [PMID: 16761366 DOI: 10.1093/bib/bbk006] [Cited by in Crossref: 98] [Cited by in F6Publishing: 66] [Article Influence: 7.0] [Reference Citation Analysis]
79 Yates LR, Campbell PJ. Evolution of the cancer genome. Nat Rev Genet 2012;13:795-806. [PMID: 23044827 DOI: 10.1038/nrg3317] [Cited by in Crossref: 394] [Cited by in F6Publishing: 342] [Article Influence: 39.4] [Reference Citation Analysis]
80 Tanaka M, Yamaguchi S, Iwasa Y. Enhanced risk of cancer in companion animals as a response to the longevity. Sci Rep 2020;10:19508. [PMID: 33177562 DOI: 10.1038/s41598-020-75684-4] [Reference Citation Analysis]
81 Tabatabaiefar MA, Sajjadi RS, Narrei S. Epigenetics and Common Non Communicable Disease. Adv Exp Med Biol 2019;1121:7-20. [PMID: 31392648 DOI: 10.1007/978-3-030-10616-4_2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
82 Wilmott JS, Zhang XD, Hersey P, Scolyer RA. The emerging important role of microRNAs in the pathogenesis, diagnosis and treatment of human cancers. Pathology 2011;43:657-71. [PMID: 21876471 DOI: 10.1097/PAT.0b013e32834a7358] [Cited by in Crossref: 31] [Cited by in F6Publishing: 15] [Article Influence: 3.1] [Reference Citation Analysis]
83 Fusco D, Gralka M, Kayser J, Anderson A, Hallatschek O. Excess of mutational jackpot events in expanding populations revealed by spatial Luria-Delbrück experiments. Nat Commun 2016;7:12760. [PMID: 27694797 DOI: 10.1038/ncomms12760] [Cited by in Crossref: 52] [Cited by in F6Publishing: 30] [Article Influence: 8.7] [Reference Citation Analysis]
84 Schöllnberger H, Beerenwinkel N, Hoogenveen R, Vineis P. Cell selection as driving force in lung and colon carcinogenesis. Cancer Res. 2010;70:6797-6803. [PMID: 20656803 DOI: 10.1158/0008-5472.can-09-4392] [Cited by in Crossref: 28] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
85 Zhang X, Fang Y, Zhao Y, Zheng W. Mathematical modeling the pathway of human breast cancer. Mathematical Biosciences 2014;253:25-9. [DOI: 10.1016/j.mbs.2014.03.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
86 Lennerz JK, Perry A, Mills JC, Huettner PC, Pfeifer JD. Mucoepidermoid carcinoma of the cervix: another tumor with the t(11; 19)-associated CRTC1-MAML2 gene fusion. Am J Surg Pathol. 2009;33:835-843. [PMID: 19092631 DOI: 10.1097/pas.0b013e318190cf5b] [Cited by in Crossref: 45] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
87 Foo J, Leder K, Michor F. Stochastic dynamics of cancer initiation. Phys Biol 2011;8:015002. [PMID: 21301064 DOI: 10.1088/1478-3975/8/1/015002] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
88 Desai MM. Statistical questions in experimental evolution. J Stat Mech 2013;2013:P01003. [DOI: 10.1088/1742-5468/2013/01/p01003] [Cited by in Crossref: 21] [Article Influence: 2.3] [Reference Citation Analysis]
89 Itan E, Tannenbaum E. Effect of chromosomal instability on the mutation-selection balance in unicellular populations. PLoS One 2012;7:e26513. [PMID: 22649487 DOI: 10.1371/journal.pone.0026513] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
90 Majumder D, Mukherjee A. A passage through systems biology to systems medicine: adoption of middle-out rational approaches towards the understanding of therapeutic outcomes in cancer. Analyst 2011;136:663-78. [DOI: 10.1039/c0an00746c] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
91 Buder T, Deutsch A, Klink B, Voss-Böhme A. Patterns of Tumor Progression Predict Small and Tissue-Specific Tumor-Originating Niches. Front Oncol 2018;8:668. [PMID: 30687642 DOI: 10.3389/fonc.2018.00668] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
92 Zhang F, Cui L, Kuo MD. Diversity of Gene Expression in Hepatocellular Carcinoma Cells. Genomics Proteomics Bioinformatics 2015;13:377-82. [PMID: 26779818 DOI: 10.1016/j.gpb.2015.07.003] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
93 Crespi B, Summers K. Evolutionary biology of cancer. Trends Ecol Evol 2005;20:545-52. [PMID: 16701433 DOI: 10.1016/j.tree.2005.07.007] [Cited by in Crossref: 163] [Cited by in F6Publishing: 134] [Article Influence: 9.6] [Reference Citation Analysis]
94 Nowak MA, Michor F, Komarova NL, Iwasa Y. Evolutionary dynamics of tumor suppressor gene inactivation. Proc Natl Acad Sci U S A 2004;101:10635-8. [PMID: 15252197 DOI: 10.1073/pnas.0400747101] [Cited by in Crossref: 74] [Cited by in F6Publishing: 61] [Article Influence: 4.1] [Reference Citation Analysis]
95 Abbott LH, Michor F. Mathematical models of targeted cancer therapy. Br J Cancer 2006;95:1136-41. [PMID: 17031409 DOI: 10.1038/sj.bjc.6603310] [Cited by in Crossref: 43] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
96 Curtius K, Wright NA, Graham TA. Evolution of Premalignant Disease. Cold Spring Harb Perspect Med 2017;7:a026542. [PMID: 28490542 DOI: 10.1101/cshperspect.a026542] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
97 Nikolov S, Wolkenhauer O, Vera J. Tumors as chaotic attractors. Mol BioSyst 2014;10:172-9. [DOI: 10.1039/c3mb70331b] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
98 Bianca C, Dogbe C, Lemarchand A. The Role of Nonconservative Interactions in the Asymptotic Limit of Thermostatted Kinetic Models. Acta Appl Math 2015;139:1-24. [DOI: 10.1007/s10440-014-9967-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
99 Beerenwinkel N, Schwarz RF, Gerstung M, Markowetz F. Cancer evolution: mathematical models and computational inference. Syst Biol 2015;64:e1-25. [PMID: 25293804 DOI: 10.1093/sysbio/syu081] [Cited by in Crossref: 186] [Cited by in F6Publishing: 127] [Article Influence: 23.3] [Reference Citation Analysis]
100 Esposito A. Cooperation of partially-transformed clones: an invisible force behind the early stages of carcinogenesis. R Soc Open Sci 2021;8:201532. [PMID: 33594337 DOI: 10.1098/rsos.201532] [Reference Citation Analysis]
101 Alvarado C, Fider NA, Wearing HJ, Komarova NL. Optimizing homeostatic cell renewal in hierarchical tissues. PLoS Comput Biol 2018;14:e1005967. [PMID: 29447149 DOI: 10.1371/journal.pcbi.1005967] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
102 Napoletani D, Signore M, Struppa DC. Cancer quasispecies and stem-like adaptive aneuploidy. F1000Res 2013;2:268. [PMID: 24715964 DOI: 10.12688/f1000research.2-268.v1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
103 Durrett R, Foo J, Leder K, Mayberry J, Michor F. Evolutionary dynamics of tumor progression with random fitness values. Theor Popul Biol 2010;78:54-66. [PMID: 20488197 DOI: 10.1016/j.tpb.2010.05.001] [Cited by in Crossref: 40] [Cited by in F6Publishing: 29] [Article Influence: 3.3] [Reference Citation Analysis]
104 Ashworth A, Lord CJ, Reis-Filho JS. Genetic interactions in cancer progression and treatment. Cell 2011;145:30-8. [PMID: 21458666 DOI: 10.1016/j.cell.2011.03.020] [Cited by in Crossref: 290] [Cited by in F6Publishing: 242] [Article Influence: 26.4] [Reference Citation Analysis]
105 Amor DR, Solé RV. Catastrophic shifts and lethal thresholds in a propagating front model of unstable tumor progression. Phys Rev E Stat Nonlin Soft Matter Phys 2014;90:022710. [PMID: 25215761 DOI: 10.1103/PhysRevE.90.022710] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
106 Letellier C, Denis F, Aguirre L. What can be learned from a chaotic cancer model? Journal of Theoretical Biology 2013;322:7-16. [DOI: 10.1016/j.jtbi.2013.01.003] [Cited by in Crossref: 64] [Cited by in F6Publishing: 35] [Article Influence: 7.1] [Reference Citation Analysis]
107 Serra MC, Haccou P. Dynamics of escape mutants. Theor Popul Biol 2007;72:167-78. [PMID: 17350060 DOI: 10.1016/j.tpb.2007.01.005] [Cited by in Crossref: 30] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
108 Gerstung M, Eriksson N, Lin J, Vogelstein B, Beerenwinkel N. The temporal order of genetic and pathway alterations in tumorigenesis. PLoS One 2011;6:e27136. [PMID: 22069497 DOI: 10.1371/journal.pone.0027136] [Cited by in Crossref: 84] [Cited by in F6Publishing: 59] [Article Influence: 7.6] [Reference Citation Analysis]
109 Dahle J, Kvam E, Stokke T. Bystander effects in UV-induced genomic instability: antioxidants inhibit delayed mutagenesis induced by ultraviolet A and B radiation. J Carcinog 2005;4:11. [PMID: 16091149 DOI: 10.1186/1477-3163-4-11] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 2.7] [Reference Citation Analysis]
110 Arya RK, Verros GD, Thapliyal D. Towards a Mathematical Model for the Viral Progression in the Pharynx. Healthcare (Basel) 2021;9:1766. [PMID: 34946492 DOI: 10.3390/healthcare9121766] [Reference Citation Analysis]
111 Bilen MA, Lin SH, Tang DG, Parikh K, Lee MH, Yeung SC, Tu SM. Maintenance Therapy Containing Metformin and/or Zyflamend for Advanced Prostate Cancer: A Case Series. Case Rep Oncol Med 2015;2015:471861. [PMID: 25861496 DOI: 10.1155/2015/471861] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
112 Aylaj B, Luciani F, Delmas V, Larue L, De Vuyst F. Melanoblast proliferation dynamics during mouse embryonic development. Modeling and validation. Journal of Theoretical Biology 2011;276:86-98. [DOI: 10.1016/j.jtbi.2011.01.041] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
113 Byrne-hoffman C, Ii D. A Quantitative Systems Pharmacology Perspective on Cancer Immunology. Processes 2015;3:235-56. [DOI: 10.3390/pr3020235] [Cited by in Crossref: 7] [Article Influence: 1.0] [Reference Citation Analysis]
114 Smart M, Goyal S, Zilman A. Roles of phenotypic heterogeneity and microenvironment feedback in early tumor development. Phys Rev E 2021;103:032407. [PMID: 33862830 DOI: 10.1103/PhysRevE.103.032407] [Reference Citation Analysis]
115 Gerlee P, Anderson AR. An evolutionary hybrid cellular automaton model of solid tumour growth. J Theor Biol 2007;246:583-603. [PMID: 17374383 DOI: 10.1016/j.jtbi.2007.01.027] [Cited by in Crossref: 147] [Cited by in F6Publishing: 97] [Article Influence: 9.8] [Reference Citation Analysis]
116 Tieu KS, Tieu RS, Martinez-Agosto JA, Sehl ME. Stem cell niche dynamics: from homeostasis to carcinogenesis. Stem Cells Int 2012;2012:367567. [PMID: 22448171 DOI: 10.1155/2012/367567] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
117 Grady WM, Carethers JM. Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology. 2008;135:1079-1099. [PMID: 18773902 DOI: 10.1053/j.gastro.2008.07.076] [Cited by in Crossref: 540] [Cited by in F6Publishing: 533] [Article Influence: 38.6] [Reference Citation Analysis]
118 Miller ET, You S, Cadaneanu RM, Kim M, Yoon J, Liu ST, Li X, Kwan L, Hodge J, Quist MJ, Grasso CS, Lewis MS, Knudsen BS, Freeman MR, Garraway IP. Chromosomal instability in untreated primary prostate cancer as an indicator of metastatic potential. BMC Cancer 2020;20:398. [PMID: 32380981 DOI: 10.1186/s12885-020-06817-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
119 Brumer Y, Michor F, Shakhnovich EI. Genetic instability and the quasispecies model. J Theor Biol 2006;241:216-22. [PMID: 16386760 DOI: 10.1016/j.jtbi.2005.11.018] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
120 Gokhale CS, Iwasa Y, Nowak MA, Traulsen A. The pace of evolution across fitness valleys. J Theor Biol 2009;259:613-20. [PMID: 19394348 DOI: 10.1016/j.jtbi.2009.04.011] [Cited by in Crossref: 37] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
121 Nowak MA, Michor F, Iwasa Y. Genetic instability and clonal expansion. J Theor Biol 2006;241:26-32. [PMID: 16405914 DOI: 10.1016/j.jtbi.2005.11.012] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
122 Zhao B, Hemann MT, Lauffenburger DA. Modeling Tumor Clonal Evolution for Drug Combinations Design. Trends Cancer 2016;2:144-58. [PMID: 28435907 DOI: 10.1016/j.trecan.2016.02.001] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 8.3] [Reference Citation Analysis]
123 de Lange MJ, Nell RJ, van der Velden PA. Scientific and clinical implications of genetic and cellular heterogeneity in uveal melanoma. Mol Biomed 2021;2:25. [PMID: 35006486 DOI: 10.1186/s43556-021-00048-x] [Reference Citation Analysis]
124 Goldman JM, Green AR, Holyoake T, Jamieson C, Mesa R, Mughal T, Pellicano F, Perrotti D, Skoda R, Vannucchi AM. Chronic myeloproliferative diseases with and without the Ph chromosome: some unresolved issues. Leukemia 2009;23:1708-15. [PMID: 19641523 DOI: 10.1038/leu.2009.142] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
125 Castro BA, Aghi MK. Bevacizumab for glioblastoma: current indications, surgical implications, and future directions. FOC 2014;37:E9. [DOI: 10.3171/2014.9.focus14516] [Cited by in Crossref: 26] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
126 Kagawa Y, Horita N, Taniguchi H, Tsuneda S. Modeling of stem cell dynamics in human colonic crypts in silico. J Gastroenterol 2014;49:263-9. [PMID: 24077809 DOI: 10.1007/s00535-013-0887-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
127 Das K, Wu R. A statistical model for the identification of genes governing the incidence of cancer with age. Theor Biol Med Model 2008;5:7. [PMID: 18416827 DOI: 10.1186/1742-4682-5-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
128 Assmus HE, Herwig R, Cho KH, Wolkenhauer O. Dynamics of biological systems: role of systems biology in medical research. Expert Rev Mol Diagn 2006;6:891-902. [PMID: 17140376 DOI: 10.1586/14737159.6.6.891] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
129 Afrasiabi K, Linskey ME, Zhou YH. Exploiting Cancer's Tactics to Make Cancer a Manageable Chronic Disease. Cancers (Basel) 2020;12:E1649. [PMID: 32580319 DOI: 10.3390/cancers12061649] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
130 Traulsen A, Iwasa Y, Nowak MA. The fastest evolutionary trajectory. J Theor Biol 2007;249:617-23. [PMID: 17900629 DOI: 10.1016/j.jtbi.2007.08.012] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
131 George JT, Levine H. Sustained Coevolution in a Stochastic Model of Cancer-Immune Interaction. Cancer Res 2020;80:811-9. [PMID: 31862779 DOI: 10.1158/0008-5472.CAN-19-2732] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
132 Dai D, Beck B, Wang X, Howk C, Li Y. Quantitative interpretation of a genetic model of carcinogenesis using computer simulations. PLoS One 2011;6:e16859. [PMID: 21408146 DOI: 10.1371/journal.pone.0016859] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
133 Kuipers J, Jahn K, Beerenwinkel N. Advances in understanding tumour evolution through single-cell sequencing. Biochim Biophys Acta Rev Cancer 2017;1867:127-38. [PMID: 28193548 DOI: 10.1016/j.bbcan.2017.02.001] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 8.4] [Reference Citation Analysis]
134 Peng T, Deng Z, He J, Li Y, Tan Y, Peng Y, Wang X, Tan W. Functional nucleic acids for cancer theranostics. Coordination Chemistry Reviews 2020;403:213080. [DOI: 10.1016/j.ccr.2019.213080] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
135 Bizzarri M, Cucina A. Tumor and the microenvironment: a chance to reframe the paradigm of carcinogenesis? Biomed Res Int 2014;2014:934038. [PMID: 25013812 DOI: 10.1155/2014/934038] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 4.5] [Reference Citation Analysis]
136 Kleffel S, Schatton T. Tumor dormancy and cancer stem cells: two sides of the same coin? Adv Exp Med Biol. 2013;734:145-179. [PMID: 23143979 DOI: 10.1007/978-1-4614-1445-2_8] [Cited by in Crossref: 71] [Cited by in F6Publishing: 71] [Article Influence: 7.9] [Reference Citation Analysis]
137 Teimouri H, Kolomeisky AB. Temporal order of mutations influences cancer initiation dynamics. Phys Biol 2021;18. [PMID: 34130273 DOI: 10.1088/1478-3975/ac0b7e] [Reference Citation Analysis]
138 Patel L, Parker B, Yang D, Zhang W. Translational genomics in cancer research: converting profiles into personalized cancer medicine. Cancer Biol Med 2013;10:214-20. [PMID: 24349831 DOI: 10.7497/j.issn.2095-3941.2013.04.005] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
139 Cukierman E, Bassi DE. Physico-mechanical aspects of extracellular matrix influences on tumorigenic behaviors. Semin Cancer Biol 2010;20:139-45. [PMID: 20452434 DOI: 10.1016/j.semcancer.2010.04.004] [Cited by in Crossref: 69] [Cited by in F6Publishing: 100] [Article Influence: 5.8] [Reference Citation Analysis]
140 Rajagopalan D, Tirado-Magallanes R, Bhatia SS, Teo WS, Sian S, Hora S, Lee KK, Zhang Y, Jadhav SP, Wu Y, Gan YH, Karnani N, Benoukraf T, Jha S. TIP60 represses activation of endogenous retroviral elements. Nucleic Acids Res 2018;46:9456-70. [PMID: 30053221 DOI: 10.1093/nar/gky659] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
141 Zhang L, Tan Y, Fan S, Zhang X, Zhang Z. Phylostratigraphic analysis of gene co-expression network reveals the evolution of functional modules for ovarian cancer. Sci Rep 2019;9:2623. [PMID: 30796309 DOI: 10.1038/s41598-019-40023-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
142 West J, Newton PK. Chemotherapeutic Dose Scheduling Based on Tumor Growth Rates Provides a Case for Low-Dose Metronomic High-Entropy Therapies. Cancer Res 2017;77:6717-28. [PMID: 28986381 DOI: 10.1158/0008-5472.CAN-17-1120] [Cited by in Crossref: 18] [Cited by in F6Publishing: 6] [Article Influence: 3.6] [Reference Citation Analysis]
143 Dingli D, Michor F. Successful therapy must eradicate cancer stem cells. Stem Cells. 2006;24:2603-2610. [PMID: 16931775 DOI: 10.1634/stemcells.2006-0136] [Cited by in Crossref: 173] [Cited by in F6Publishing: 138] [Article Influence: 10.8] [Reference Citation Analysis]
144 Bellomo N, Elaiw A, Althiabi AM, Alghamdi MA. On the interplay between mathematics and biology: hallmarks toward a new systems biology. Phys Life Rev 2015;12:44-64. [PMID: 25529144 DOI: 10.1016/j.plrev.2014.12.002] [Cited by in Crossref: 39] [Cited by in F6Publishing: 11] [Article Influence: 4.9] [Reference Citation Analysis]
145 Wolf AM. The tumor suppression theory of aging. Mech Ageing Dev 2021;200:111583. [PMID: 34637937 DOI: 10.1016/j.mad.2021.111583] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
146 Bellomo N, Bellouquid A. On the derivation of macroscopic tissue equations from hybrid models of the kinetic theory of multicellular growing systems — The effect of global equilibrium. Nonlinear Analysis: Hybrid Systems 2009;3:215-24. [DOI: 10.1016/j.nahs.2009.01.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
147 Gatti G, Maresca G, Natoli M, Florenzano F, Nicolin A, Felsani A, D'Agnano I. MYC prevents apoptosis and enhances endoreduplication induced by paclitaxel. PLoS One 2009;4:e5442. [PMID: 19421315 DOI: 10.1371/journal.pone.0005442] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
148 Fleck JL, Pavel AB, Cassandras CG. Integrating mutation and gene expression cross-sectional data to infer cancer progression. BMC Syst Biol 2016;10:12. [PMID: 26810975 DOI: 10.1186/s12918-016-0255-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
149 Iwasa Y, Michor F, Komarova NL, Nowak MA. Population genetics of tumor suppressor genes. Journal of Theoretical Biology 2005;233:15-23. [DOI: 10.1016/j.jtbi.2004.09.001] [Cited by in Crossref: 49] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]
150 Goriely A, Robertson-tessi M, Tabor M, Vandiver R. Elastic Growth Models. In: Mondaini RP, Pardalos PM, editors. Mathematical Modelling of Biosystems. Berlin: Springer Berlin Heidelberg; 2008. pp. 1-44. [DOI: 10.1007/978-3-540-76784-8_1] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
151 Rozhok A, DeGregori J. A generalized theory of age-dependent carcinogenesis. Elife 2019;8:e39950. [PMID: 31034356 DOI: 10.7554/eLife.39950] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
152 Doubeni CA, Gabler NB, Wheeler CM, McCarthy AM, Castle PE, Halm EA, Schnall MD, Skinner CS, Tosteson ANA, Weaver DL, Vachani A, Mehta SJ, Rendle KA, Fedewa SA, Corley DA, Armstrong K. Timely follow-up of positive cancer screening results: A systematic review and recommendations from the PROSPR Consortium. CA Cancer J Clin 2018;68:199-216. [PMID: 29603147 DOI: 10.3322/caac.21452] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 7.5] [Reference Citation Analysis]
153 Burgio E, Piscitelli P, Colao A. Environmental Carcinogenesis and Transgenerational Transmission of Carcinogenic Risk: From Genetics to Epigenetics. Int J Environ Res Public Health 2018;15:E1791. [PMID: 30127322 DOI: 10.3390/ijerph15081791] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
154 Whittle MC, Hingorani SR. Runx3 and Cell Fate Decisions in Pancreas Cancer. Adv Exp Med Biol 2017;962:333-52. [PMID: 28299667 DOI: 10.1007/978-981-10-3233-2_21] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
155 Melissourgos T, Nikoletseas SE, Raptopoulos CL, Spirakis PG. An extension of the Moran process using type-specific connection graphs. Journal of Computer and System Sciences 2022;124:77-96. [DOI: 10.1016/j.jcss.2021.07.007] [Reference Citation Analysis]
156 Hu J, Zhang C, Zhu K, Zhang L, Cai T, Zhan T, Luo X, Dong Y. Is increased symptom interval associated with advanced stage and poorer outcome? A prospective multicenter study of 220 patients with osteosarcoma around the knee. Cancer Epidemiol 2020;67:101776. [PMID: 32645592 DOI: 10.1016/j.canep.2020.101776] [Reference Citation Analysis]
157 Xi S, Dyer KF, Kimak M, Zhang Q, Gooding WE, Chaillet JR, Chai RL, Ferrell RE, Zamboni B, Hunt J, Grandis JR. Decreased STAT1 expression by promoter methylation in squamous cell carcinogenesis. J Natl Cancer Inst 2006;98:181-9. [PMID: 16449678 DOI: 10.1093/jnci/djj020] [Cited by in Crossref: 63] [Cited by in F6Publishing: 53] [Article Influence: 3.9] [Reference Citation Analysis]
158 Leon Chen L, Beck C. A superstatistical model of metastasis and cancer survival. Physica A: Statistical Mechanics and its Applications 2008;387:3162-72. [DOI: 10.1016/j.physa.2008.01.116] [Cited by in Crossref: 40] [Article Influence: 2.9] [Reference Citation Analysis]
159 Greaves M. Darwinian medicine: a case for cancer. Nat Rev Cancer 2007;7:213-21. [PMID: 17301845 DOI: 10.1038/nrc2071] [Cited by in Crossref: 116] [Cited by in F6Publishing: 95] [Article Influence: 7.7] [Reference Citation Analysis]
160 Tao L, Qiu J, Jiang M, Song W, Yeh S, Yu H, Zang L, Xia S, Chang C. Infiltrating T Cells Promote Bladder Cancer Progression via Increasing IL1→Androgen Receptor→HIF1α→VEGFa Signals. Mol Cancer Ther 2016;15:1943-51. [PMID: 27196763 DOI: 10.1158/1535-7163.MCT-15-0306] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
161 Mongre RK, Mishra CB, Shukla AK, Prakash A, Jung S, Ashraf-Uz-Zaman M, Lee MS. Emerging Importance of Tyrosine Kinase Inhibitors against Cancer: Quo Vadis to Cure? Int J Mol Sci 2021;22:11659. [PMID: 34769090 DOI: 10.3390/ijms222111659] [Reference Citation Analysis]
162 Zhu T, Hu Y, Ma ZM, Zhang DX, Li T, Yang Z. Efficient simulation under a population genetics model of carcinogenesis. Bioinformatics 2011;27:837-43. [PMID: 21247938 DOI: 10.1093/bioinformatics/btr025] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
163 Costa JM, Orlande HR, Velho HF, de Pinho ST, Dulikravich GS, Cotta RM, da Cunha Neto SH. Estimation of Tumor Size Evolution Using Particle Filters. J Comput Biol 2015;22:649-65. [PMID: 25973723 DOI: 10.1089/cmb.2014.0003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
164 Riester M, Stephan-Otto Attolini C, Downey RJ, Singer S, Michor F. A differentiation-based phylogeny of cancer subtypes. PLoS Comput Biol 2010;6:e1000777. [PMID: 20463876 DOI: 10.1371/journal.pcbi.1000777] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
165 Misra N, Szczurek E, Vingron M. Inferring the paths of somatic evolution in cancer. Bioinformatics 2014;30:2456-63. [PMID: 24812340 DOI: 10.1093/bioinformatics/btu319] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
166 Antonopoulos M, Dionysiou D, Stamatakos G, Uzunoglu N. Three-dimensional tumor growth in time-varying chemical fields: a modeling framework and theoretical study. BMC Bioinformatics 2019;20:442. [PMID: 31455206 DOI: 10.1186/s12859-019-2997-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
167 Dingli D, Traulsen A, Lenaerts T, Pacheco JM. Evolutionary dynamics of chronic myeloid leukemia. Genes Cancer 2010;1:309-15. [PMID: 21779452 DOI: 10.1177/1947601910371122] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
168 Martens EA, Kostadinov R, Maley CC, Hallatschek O. Spatial structure increases the waiting time for cancer. New J Phys 2011;13:115014. [PMID: 22707911 DOI: 10.1088/1367-2630/13/11/115014] [Cited by in Crossref: 61] [Cited by in F6Publishing: 53] [Article Influence: 5.5] [Reference Citation Analysis]
169 Haeno H, Iwasa Y, Michor F. The evolution of two mutations during clonal expansion. Genetics. 2007;177:2209-2221. [PMID: 18073428 DOI: 10.1534/genetics.107.078915] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 3.4] [Reference Citation Analysis]
170 Zhou JX, Cisneros L, Knijnenburg T, Trachana K, Davies P, Huang S. Phylostratigraphic analysis of tumor and developmental transcriptomes reveals relationship between oncogenesis, phylogenesis and ontogenesis. Converg Sci Phys Oncol 2018;4:025002. [DOI: 10.1088/2057-1739/aab1b0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
171 Lee N, Barthel SR, Schatton T. Melanoma stem cells and metastasis: mimicking hematopoietic cell trafficking? Lab Invest 2014;94:13-30. [PMID: 24126889 DOI: 10.1038/labinvest.2013.116] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 5.0] [Reference Citation Analysis]
172 Ashcroft P, Michor F, Galla T. Stochastic tunneling and metastable states during the somatic evolution of cancer. Genetics 2015;199:1213-28. [PMID: 25624316 DOI: 10.1534/genetics.114.171553] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
173 Page KM. Up a gear? The significance of an elevated mutation rate in tumorigenesis. Physics of Life Reviews 2007;4:116-27. [DOI: 10.1016/j.plrev.2007.04.001] [Reference Citation Analysis]
174 Gerstung M, Nakhoul H, Beerenwinkel N. Evolutionary Games with Affine Fitness Functions: Applications to Cancer. Dyn Games Appl 2011;1:370-85. [DOI: 10.1007/s13235-011-0029-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
175 Nishi A. Evolution and social epidemiology. Social Science & Medicine 2015;145:132-7. [DOI: 10.1016/j.socscimed.2015.08.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
176 Wu R, Lin M. Functional mapping - how to map and study the genetic architecture of dynamic complex traits. Nat Rev Genet 2006;7:229-37. [PMID: 16485021 DOI: 10.1038/nrg1804] [Cited by in Crossref: 219] [Cited by in F6Publishing: 195] [Article Influence: 13.7] [Reference Citation Analysis]
177 Ryser MD, Gravitt PE, Myers ER. Mechanistic mathematical models: An underused platform for HPV research. Papillomavirus Res 2017;3:46-9. [PMID: 28720456 DOI: 10.1016/j.pvr.2017.01.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
178 Beerenwinkel N, Antal T, Dingli D, Traulsen A, Kinzler KW, Velculescu VE, Vogelstein B, Nowak MA. Genetic progression and the waiting time to cancer. PLoS Comput Biol 2007;3:e225. [PMID: 17997597 DOI: 10.1371/journal.pcbi.0030225] [Cited by in Crossref: 270] [Cited by in F6Publishing: 219] [Article Influence: 19.3] [Reference Citation Analysis]
179 Azimzade Y, Ali Saberi A. Short-range migration can alter evolutionary dynamics in solid tumors. J Stat Mech 2019;2019:103502. [DOI: 10.1088/1742-5468/ab4983] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
180 Teimouri H, Kochugaeva MP, Kolomeisky AB. Elucidating the correlations between cancer initiation times and lifetime cancer risks. Sci Rep 2019;9:18940. [PMID: 31831779 DOI: 10.1038/s41598-019-55300-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
181 Tu SM, Bilen MA, Tannir NM. Personalised cancer care: promises and challenges of targeted therapy. J R Soc Med 2016;109:98-105. [PMID: 26933155 DOI: 10.1177/0141076816631154] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
182 Wang Y, Xia Z, Deng J, Xie X, Gong M, Ma X. TLGP: a flexible transfer learning algorithm for gene prioritization based on heterogeneous source domain. BMC Bioinformatics 2021;22:274. [PMID: 34433414 DOI: 10.1186/s12859-021-04190-9] [Reference Citation Analysis]
183 Murgia C, Pritchard JK, Kim SY, Fassati A, Weiss RA. Clonal origin and evolution of a transmissible cancer. Cell 2006;126:477-87. [PMID: 16901782 DOI: 10.1016/j.cell.2006.05.051] [Cited by in Crossref: 258] [Cited by in F6Publishing: 206] [Article Influence: 16.1] [Reference Citation Analysis]
184 Ascolani G, Liò P. Modeling breast cancer progression to bone: how driver mutation order and metabolism matter. BMC Med Genomics 2019;12:106. [PMID: 31345216 DOI: 10.1186/s12920-019-0541-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
185 Klijn C, Bot J, Adams DJ, Reinders M, Wessels L, Jonkers J. Identification of networks of co-occurring, tumor-related DNA copy number changes using a genome-wide scoring approach. PLoS Comput Biol 2010;6:e1000631. [PMID: 20052266 DOI: 10.1371/journal.pcbi.1000631] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
186 Bellouquid A, De Angelis E. From kinetic models of multicellular growing systems to macroscopic biological tissue models. Nonlinear Analysis: Real World Applications 2011;12:1111-22. [DOI: 10.1016/j.nonrwa.2010.09.005] [Cited by in Crossref: 31] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
187 Grajzel D, Derényi I, Szöllősi GJ. A compartment size-dependent selective threshold limits mutation accumulation in hierarchical tissues. Proc Natl Acad Sci U S A 2020;117:1606-11. [PMID: 31907322 DOI: 10.1073/pnas.1913104117] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
188 Li L, Zhang X, Tian T, Pang L. Mathematical modelling the pathway of genomic instability in lung cancer. Sci Rep 2019;9:14136. [PMID: 31575883 DOI: 10.1038/s41598-019-50500-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
189 Herzog CR, Desai D, Amin S. Array CGH analysis reveals chromosomal aberrations in mouse lung adenocarcinomas induced by the human lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Biochem Biophys Res Commun 2006;341:856-63. [PMID: 16455056 DOI: 10.1016/j.bbrc.2006.01.043] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
190 Urbach D, Lupien M, Karagas MR, Moore JH. Cancer heterogeneity: origins and implications for genetic association studies. Trends Genet 2012;28:538-43. [PMID: 22858414 DOI: 10.1016/j.tig.2012.07.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
191 Khordad R, Rastegar Sedehi HR. Modeling cancer growth and its treatment by means of statistical mechanics entropy. Eur Phys J Plus 2016;131. [DOI: 10.1140/epjp/i2016-16291-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
192 Chen J, Yue H, Ouyang Q. Correlation between oncogenic mutations and parameter sensitivity of the apoptosis pathway model. PLoS Comput Biol 2014;10:e1003451. [PMID: 24465201 DOI: 10.1371/journal.pcbi.1003451] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
193 Manem VSK, Salgado R, Aftimos P, Sotiriou C, Haibe-Kains B. Network science in clinical trials: A patient-centered approach. Semin Cancer Biol 2018;52:135-50. [PMID: 29278737 DOI: 10.1016/j.semcancer.2017.12.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
194 Kaveh K. Stem Cell Evolutionary Dynamics of Differentiation and Plasticity. Curr Stem Cell Rep 2017;3:366-72. [DOI: 10.1007/s40778-017-0109-1] [Reference Citation Analysis]
195 Greaves M. Evolutionary determinants of cancer. Cancer Discov 2015;5:806-20. [PMID: 26193902 DOI: 10.1158/2159-8290.CD-15-0439] [Cited by in Crossref: 231] [Cited by in F6Publishing: 1] [Article Influence: 33.0] [Reference Citation Analysis]
196 Jiménez-Sánchez J, Martínez-Rubio Á, Popov A, Pérez-Beteta J, Azimzade Y, Molina-García D, Belmonte-Beitia J, Calvo GF, Pérez-García VM. A mesoscopic simulator to uncover heterogeneity and evolutionary dynamics in tumors. PLoS Comput Biol 2021;17:e1008266. [PMID: 33566821 DOI: 10.1371/journal.pcbi.1008266] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
197 Ferreira AL, Lipowska D, Lipowski A. Statistical mechanics model of angiogenic tumor growth. Phys Rev E Stat Nonlin Soft Matter Phys 2012;85:010901. [PMID: 22400505 DOI: 10.1103/PhysRevE.85.010901] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
198 Michor F, Iwasa Y. Dynamics of metastasis suppressor gene inactivation. J Theor Biol 2006;241:676-89. [PMID: 16497335 DOI: 10.1016/j.jtbi.2006.01.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
199 Rodriguez-Lee M, Kuhn P, Webb DR. Advancing cancer patient care by integrating circulating tumor cell technology to understand the spatial and temporal dynamics of cancer. Drug Dev Res 2014;75:384-92. [PMID: 25195582 DOI: 10.1002/ddr.21225] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
200 Andersen M, Sajid Z, Pedersen RK, Gudmand-Hoeyer J, Ellervik C, Skov V, Kjær L, Pallisgaard N, Kruse TA, Thomassen M, Troelsen J, Hasselbalch HC, Ottesen JT. Mathematical modelling as a proof of concept for MPNs as a human inflammation model for cancer development. PLoS One 2017;12:e0183620. [PMID: 28859112 DOI: 10.1371/journal.pone.0183620] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
201 Collis J, Hubbard ME, O'dea RD. A multi-scale analysis of drug transport and response for a multi-phase tumour model. Eur J Appl Math 2017;28:499-534. [DOI: 10.1017/s0956792516000413] [Cited by in Crossref: 9] [Article Influence: 1.5] [Reference Citation Analysis]
202 Baumgart M, Werther M, Bockholt A, Scheurer M, Rüschoff J, Dietmaier W, Ghadimi BM, Heinmöller E. Genomic Instability at Both the Base Pair Level and the Chromosomal Level Is Detectable in Earliest PanIN Lesions in Tissues of Chronic Pancreatitis. Pancreas 2010;39:1093-103. [DOI: 10.1097/mpa.0b013e3181dc62f6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
203 Grady WM, Carethers JM. Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology. 2008;135:1079-1099. [PMID: 18773902 DOI: 10.1053/j.gastro.2008.07.076.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
204 Brumer Y, Shakhnovich EI. Importance of DNA repair in tumor suppression. Phys Rev E Stat Nonlin Soft Matter Phys 2004;70:061912. [PMID: 15697407 DOI: 10.1103/PhysRevE.70.061912] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
205 Rajagopalan D, Jha S. An epi(c)genetic war: Pathogens, cancer and human genome. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2018;1869:333-45. [DOI: 10.1016/j.bbcan.2018.04.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
206 Lee H, Kim N, Yoo YJ, Kim H, Jeong E, Choi S, Moon SU, Oh SH, Mills GB, Yoon S, Kim WY. β-catenin/TCF activity regulates IGF-1R tyrosine kinase inhibitor sensitivity in colon cancer. Oncogene 2018;37:5466-75. [PMID: 29895971 DOI: 10.1038/s41388-018-0362-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
207 Burini D, Angelis ED, Lachowicz M. A Continuous–Time Markov Chain Modeling Cancer–Immune System Interactions. Communications in Applied and Industrial Mathematics 2018;9:106-18. [DOI: 10.2478/caim-2018-0018] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
208 Michor F. Mathematical models of cancer stem cells. J Clin Oncol 2008;26:2854-61. [PMID: 18539964 DOI: 10.1200/JCO.2007.15.2421] [Cited by in Crossref: 93] [Cited by in F6Publishing: 34] [Article Influence: 6.6] [Reference Citation Analysis]
209 Pepper JW, Scott Findlay C, Kassen R, Spencer SL, Maley CC. Cancer research meets evolutionary biology. Evol Appl 2009;2:62-70. [PMID: 25567847 DOI: 10.1111/j.1752-4571.2008.00063.x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 52] [Article Influence: 10.1] [Reference Citation Analysis]
210 Bauer B, Siebert R, Traulsen A. Cancer initiation with epistatic interactions between driver and passenger mutations. Journal of Theoretical Biology 2014;358:52-60. [DOI: 10.1016/j.jtbi.2014.05.018] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 3.1] [Reference Citation Analysis]
211 Michor F, Liphardt J, Ferrari M, Widom J. What does physics have to do with cancer? Nat Rev Cancer 2011;11:657-70. [PMID: 21850037 DOI: 10.1038/nrc3092] [Cited by in Crossref: 129] [Cited by in F6Publishing: 112] [Article Influence: 11.7] [Reference Citation Analysis]
212 Corbellini G, Preti C. The evolution of the biomedical paradigm in oncology: implications for cancer therapy. Adv Exp Med Biol 2008;610:5-18. [PMID: 18593012 DOI: 10.1007/978-0-387-73898-7_2] [Reference Citation Analysis]
213 Attolini CS, Michor F. Evolutionary theory of cancer. Ann N Y Acad Sci 2009;1168:23-51. [PMID: 19566702 DOI: 10.1111/j.1749-6632.2009.04880.x] [Cited by in Crossref: 78] [Cited by in F6Publishing: 64] [Article Influence: 6.0] [Reference Citation Analysis]
214 Fornari C, Beccuti M, Lanzardo S, Conti L, Balbo G, Cavallo F, Calogero RA, Cordero F. A mathematical-biological joint effort to investigate the tumor-initiating ability of Cancer Stem Cells. PLoS One 2014;9:e106193. [PMID: 25184361 DOI: 10.1371/journal.pone.0106193] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
215 Baker SG, Soto AM, Sonnenschein C, Cappuccio A, Potter JD, Kramer BS. Plausibility of stromal initiation of epithelial cancers without a mutation in the epithelium: a computer simulation of morphostats. BMC Cancer 2009;9:89. [PMID: 19309499 DOI: 10.1186/1471-2407-9-89] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
216 Shpak M, Goldberg MM, Cowperthwaite MC. Rapid and convergent evolution in the glioblastoma multiforme genome. Genomics 2015;105:159-67. [PMID: 25576655 DOI: 10.1016/j.ygeno.2014.12.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
217 Bajpai M, Kessel R, Bhagat T, Nischal S, Yu Y, Verma A, Das KM. High resolution integrative analysis reveals widespread genetic and epigenetic changes after chronic in-vitro acid and bile exposure in Barrett's epithelium cells. Genes Chromosomes Cancer 2013;52:1123-32. [PMID: 24123713 DOI: 10.1002/gcc.22106] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
218 Holbek S, Bendtsen KM, Juul J. Moderate stem-cell telomere shortening rate postpones cancer onset in a stochastic model. Phys Rev E 2013;88. [DOI: 10.1103/physreve.88.042706] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
219 Zhang L, Zhang X, Fan S, Zhang Z. Identification of modules and hub genes associated with platinum-based chemotherapy resistance and treatment response in ovarian cancer by weighted gene co-expression network analysis. Medicine (Baltimore) 2019;98:e17803. [PMID: 31689861 DOI: 10.1097/MD.0000000000017803] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
220 Bellouquid A, De Angelis E, Knopoff D. FROM THE MODELING OF THE IMMUNE HALLMARKS OF CANCER TO A BLACK SWAN IN BIOLOGY. Math Models Methods Appl Sci 2013;23:949-78. [DOI: 10.1142/s0218202512500650] [Cited by in Crossref: 64] [Article Influence: 7.1] [Reference Citation Analysis]
221 Bellomo N, Delitala M. From the mathematical kinetic, and stochastic game theory to modelling mutations, onset, progression and immune competition of cancer cells. Physics of Life Reviews 2008;5:183-206. [DOI: 10.1016/j.plrev.2008.07.001] [Cited by in Crossref: 123] [Cited by in F6Publishing: 72] [Article Influence: 8.8] [Reference Citation Analysis]
222 Kim J, Jang J, Cho DW. Recapitulating the Cancer Microenvironment Using Bioprinting Technology for Precision Medicine. Micromachines (Basel) 2021;12:1122. [PMID: 34577765 DOI: 10.3390/mi12091122] [Reference Citation Analysis]
223 Woo YH, Li WH. DNA replication timing and selection shape the landscape of nucleotide variation in cancer genomes. Nat Commun 2012;3:1004. [PMID: 22893128 DOI: 10.1038/ncomms1982] [Cited by in Crossref: 90] [Cited by in F6Publishing: 81] [Article Influence: 10.0] [Reference Citation Analysis]
224 Kaveh K, Manem VSK, Kohandel M, Sivaloganathan S. Modeling age-dependent radiation-induced second cancer risks and estimation of mutation rate: an evolutionary approach. Radiat Environ Biophys 2015;54:25-36. [PMID: 25404281 DOI: 10.1007/s00411-014-0576-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
225 Benton ML, Abraham A, LaBella AL, Abbot P, Rokas A, Capra JA. The influence of evolutionary history on human health and disease. Nat Rev Genet 2021;22:269-83. [PMID: 33408383 DOI: 10.1038/s41576-020-00305-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
226 Lecca P, Casiraghi N, Demichelis F. Defining order and timing of mutations during cancer progression: the TO-DAG probabilistic graphical model. Front Genet 2015;6:309. [PMID: 26528329 DOI: 10.3389/fgene.2015.00309] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
227 Dinicola S, D'Anselmi F, Pasqualato A, Proietti S, Lisi E, Cucina A, Bizzarri M. A systems biology approach to cancer: fractals, attractors, and nonlinear dynamics. OMICS 2011;15:93-104. [PMID: 21319994 DOI: 10.1089/omi.2010.0091] [Cited by in Crossref: 43] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
228 Sottoriva A, Kang H, Ma Z, Graham TA, Salomon MP, Zhao J, Marjoram P, Siegmund K, Press MF, Shibata D, Curtis C. A Big Bang model of human colorectal tumor growth. Nat Genet. 2015;47:209-216. [PMID: 25665006 DOI: 10.1038/ng.3214] [Cited by in Crossref: 608] [Cited by in F6Publishing: 523] [Article Influence: 86.9] [Reference Citation Analysis]
229 Komarova NL. Spatial stochastic models for cancer initiation and progression. Bull Math Biol 2006;68:1573-99. [PMID: 16832734 DOI: 10.1007/s11538-005-9046-8] [Cited by in Crossref: 61] [Cited by in F6Publishing: 52] [Article Influence: 3.8] [Reference Citation Analysis]
230 Diaz-Cano SJ. Tumor heterogeneity: mechanisms and bases for a reliable application of molecular marker design. Int J Mol Sci 2012;13:1951-2011. [PMID: 22408433 DOI: 10.3390/ijms13021951] [Cited by in Crossref: 86] [Cited by in F6Publishing: 80] [Article Influence: 8.6] [Reference Citation Analysis]
231 Wani AA, Sharma N, Shouche YS, Bapat SA. Nuclear–mitochondrial genomic profiling reveals a pattern of evolution in epithelial ovarian tumor stem cells. Oncogene 2006;25:6336-44. [DOI: 10.1038/sj.onc.1209649] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
232 Emily M, François O. Conditional coalescent trees with two mutation rates and their application to genomic instability. Genetics 2006;172:1809-20. [PMID: 16387889 DOI: 10.1534/genetics.105.044099] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
233 Giancotti FG. Mechanisms governing metastatic dormancy and reactivation. Cell 2013;155:750-64. [PMID: 24209616 DOI: 10.1016/j.cell.2013.10.029] [Cited by in Crossref: 315] [Cited by in F6Publishing: 288] [Article Influence: 39.4] [Reference Citation Analysis]
234 Posada D. Cancer Molecular Evolution. J Mol Evol 2015;81:81-3. [PMID: 26289731 DOI: 10.1007/s00239-015-9695-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
235 Dingli D, Pacheco JM, Traulsen A. Multiple mutant clones in blood rarely coexist. Phys Rev E Stat Nonlin Soft Matter Phys 2008;77:021915. [PMID: 18352059 DOI: 10.1103/PhysRevE.77.021915] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
236 Mahdipour-Shirayeh A, Darooneh AH, Long AD, Komarova NL, Kohandel M. Genotype by random environmental interactions gives an advantage to non-favored minor alleles. Sci Rep 2017;7:5193. [PMID: 28701726 DOI: 10.1038/s41598-017-05375-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
237 Novozhilov AS, Berezovskaya FS, Koonin EV, Karev GP. Mathematical modeling of tumor therapy with oncolytic viruses: regimes with complete tumor elimination within the framework of deterministic models. Biol Direct 2006;1:6. [PMID: 16542009 DOI: 10.1186/1745-6150-1-6] [Cited by in Crossref: 57] [Cited by in F6Publishing: 35] [Article Influence: 3.6] [Reference Citation Analysis]
238 Grizzi F, Chiriva-Internati M. Cancer: looking for simplicity and finding complexity. Cancer Cell Int. 2006;6:4. [PMID: 16480511 DOI: 10.1186/1475-2867-6-4] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
239 Hu Y, Ru N, Xiao H, Chaturbedi A, Hoa NT, Tian XJ, Zhang H, Ke C, Yan F, Nelson J, Li Z, Gramer R, Yu L, Siegel E, Zhang X, Jia Z, Jadus MR, Limoli CL, Linskey ME, Xing J, Zhou YH. Tumor-specific chromosome mis-segregation controls cancer plasticity by maintaining tumor heterogeneity. PLoS One 2013;8:e80898. [PMID: 24282558 DOI: 10.1371/journal.pone.0080898] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]